VVD-133214 drug page Clinical trials

Trials with VVD-133214

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

2Trials
2Recruiting
18Countries
420Planned patients

Showing 1–2 of 2

A Study to Evaluate the Efficacy of VVD-133214 in Combination With Pembrolizumab Compared With Pembrolizumab Alone in Participants With Advanced Cancer of the Colon or Rectum
Recruiting Phase 2 140 patients NCT07811193

Researchers are looking for a better way to treat people with advanced colorectal cancer. Colorectal cancer (cancer of the colon or rectum) is one of the most common cancers worldwide. Treatments include surgery, chemotherapy, radiotherap…

United States, Argentina, Belgium, Brazil and 7 more Sept 2026 – Dec 2030 Interventional
Combined with: Pembrolizumab
A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors
Recruiting Phase 1 280 patients NCT06004245

This is a first-in-human, Phase I, open-label, multicenter, dose-escalation and dose expansion study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary anti-tumor activity of VVD-133214 monotherapy, a…

United States, Australia, Belgium, Canada and 7 more Jan 2024 – May 2027 Interventional
Combined with: BevacizumabPembrolizumab

Where the recruiting trials are